ArticleCancers2025

Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

Tim Flaadt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.